Salvatore Giovine

Insider Reports History

Location
Waltham, MA
Signature
/s/ Chris Frankenfield, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Salvatore Giovine:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (right to buy) 49,500 22 Feb 2022 Direct

Insider Reports Filed by Salvatore Giovine

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XLO Xilio Therapeutics, Inc. 22 Feb 2022 1 $0 4 CHIEF FINANCIAL OFFICER 24 Feb 2022, 16:30
XLO Xilio Therapeutics, Inc. 21 Oct 2021 1 $0 4 Chief Financial Officer 25 Oct 2021, 17:16
XLO Xilio Therapeutics, Inc. 21 Oct 2021 0 $0 3 Chief Financial Officer 21 Oct 2021, 20:44